ES254048A1 - Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido - Google Patents

Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido

Info

Publication number
ES254048A1
ES254048A1 ES0254048A ES254048A ES254048A1 ES 254048 A1 ES254048 A1 ES 254048A1 ES 0254048 A ES0254048 A ES 0254048A ES 254048 A ES254048 A ES 254048A ES 254048 A1 ES254048 A1 ES 254048A1
Authority
ES
Spain
Prior art keywords
plastic
specified
drug
salts
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0254048A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of ES254048A1 publication Critical patent/ES254048A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES0254048A 1958-12-19 1959-12-09 Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido Expired ES254048A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US781433A US3087860A (en) 1958-12-19 1958-12-19 Method of prolonging release of drug from a precompressed solid carrier

Publications (1)

Publication Number Publication Date
ES254048A1 true ES254048A1 (es) 1960-02-16

Family

ID=25122720

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0254048A Expired ES254048A1 (es) 1958-12-19 1959-12-09 Metodo de prolongaciën del desprendimiento de una droga de un excipiente sëlido

Country Status (4)

Country Link
US (1) US3087860A (fr)
BE (1) BE585579A (fr)
ES (1) ES254048A1 (fr)
GB (1) GB908016A (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138544A (en) * 1961-05-03 1964-06-23 British Drug Houses Canada Ltd Microbial sensitivity testing device
US3198700A (en) * 1961-05-29 1965-08-03 Blessings Inc Sedative tablet and method for producing the same
NL297357A (fr) * 1962-08-31
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
US3440320A (en) * 1964-06-18 1969-04-22 Mortimer D Sackler Chelated suppository and method of using same
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
IE32806B1 (en) * 1968-05-21 1973-12-12 American Home Prod Sustained release drug composition
DE2239206A1 (de) * 1971-08-12 1973-03-15 Hydrophilics Int Inc Copolymer
US3995632A (en) * 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4851231A (en) * 1982-12-13 1989-07-25 Alza Corporation System for delivering drug in selected environment of use
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
DE3827214A1 (de) * 1988-08-11 1990-02-15 Roehm Gmbh Retardierte arzneiform und verfahren zu ihrer herstellung
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US7225024B2 (en) * 2003-09-30 2007-05-29 Cardiac Pacemakers, Inc. Sensors having protective eluting coating and method therefor
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20070009564A1 (en) * 2005-06-22 2007-01-11 Mcclain James B Drug/polymer composite materials and methods of making the same
US20090062909A1 (en) * 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
KR101406415B1 (ko) 2005-07-15 2014-06-19 미셀 테크놀로지즈, 인코포레이티드 제어된 형태의 약물 분말을 함유하는 중합체 코팅
RU2008113439A (ru) * 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
EA014739B1 (ru) * 2005-09-09 2011-02-28 Лабофарм Инк. Композиция тразодона для введения один раз в день
CA2996768C (fr) 2006-04-26 2020-12-08 Micell Technologies, Inc. Revetements contenant plusieurs medicaments
WO2008042909A2 (fr) 2006-10-02 2008-04-10 Micell Technologies Inc. Sutures chirurgicales ayant une résistance accrue
CA2667228C (fr) * 2006-10-23 2015-07-14 Micell Technologies, Inc. Support pour charger electriquement un substrat au cours de l'enduction
CN101711137B (zh) 2007-01-08 2014-10-22 米歇尔技术公司 具有可生物降解层的支架
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
US9433516B2 (en) 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
CN101854962B (zh) * 2007-04-17 2015-12-16 米歇尔技术公司 具有生物降解性层的支架
WO2008148013A1 (fr) * 2007-05-25 2008-12-04 Micell Technologies, Inc. Films de polymères pour le revêtement des dispositifs médicaux
US20100298928A1 (en) * 2007-10-19 2010-11-25 Micell Technologies, Inc. Drug Coated Stents
JP5608160B2 (ja) 2008-04-17 2014-10-15 ミセル テクノロジーズ、インコーポレイテッド 生体吸収性の層を有するステント
EP2313122B1 (fr) * 2008-07-17 2019-03-06 Micell Technologies, Inc. Dispositif médical d administration de médicament
WO2010040113A1 (fr) * 2008-10-03 2010-04-08 Salix Pharmaceuticals, Ltd. Compositions et procédés permettant de traiter les maladies intestinales à l’aide de mésalamine granulée
US8834913B2 (en) * 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
US20100239635A1 (en) * 2009-03-23 2010-09-23 Micell Technologies, Inc. Drug delivery medical device
WO2010111196A2 (fr) * 2009-03-23 2010-09-30 Micell Technologies, Inc. Endoprothèses périphériques dotées de couches
WO2010111238A2 (fr) * 2009-03-23 2010-09-30 Micell Technologies, Inc. Polymères biodégradables améliorés
JP2012522589A (ja) 2009-04-01 2012-09-27 ミシェル テクノロジーズ，インコーポレイテッド 被覆ステント
EP2453834A4 (fr) 2009-07-16 2014-04-16 Micell Technologies Inc Dispositif médical distributeur de médicament
EP2531140B1 (fr) 2010-02-02 2017-11-01 Micell Technologies, Inc. Endoprothèse et système de pose d'endoprothèse avec une capacité améliorée de pose
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
US10232092B2 (en) 2010-04-22 2019-03-19 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
EP2593039B1 (fr) 2010-07-16 2022-11-30 Micell Technologies, Inc. Dispositif médical d'administration de médicament
CA2810842C (fr) 2010-09-09 2018-06-26 Micell Technologies, Inc. Formes pharmaceutiques de type macrolides
WO2012166819A1 (fr) 2011-05-31 2012-12-06 Micell Technologies, Inc. Système et procédé de formation de revêtement transférable à élution de médicament, libéré dans le temps
CA2841360A1 (fr) 2011-07-15 2013-01-24 Micell Technologies, Inc. Dispositif medical d'administration de medicament
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
EP2967803B1 (fr) 2013-03-12 2023-12-27 Micell Technologies, Inc. Implants biomédicaux bioabsorbables
EP2996629B1 (fr) 2013-05-15 2021-09-22 Micell Technologies, Inc. Implants biomedicaux bioabsorbables

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US312041A (en) * 1885-02-10 Process of making pills
USRE24090E (en) * 1955-11-15 Impregnated salt tablet
CA548310A (fr) * 1957-11-05 M. O. Honey Eric Diaphragmes pour usage dans procedes a echange d'ions
NL44885C (fr) * 1935-11-09
US2385920A (en) * 1941-12-19 1945-10-02 Pittsburgh Plate Glass Co Plasticization of plastics
US2478182A (en) * 1945-01-16 1949-08-09 William V Consolazio Sodium chloride tablet
GB665073A (en) * 1948-11-10 1952-01-16 Jacques Loewe Res Foundation I Process of preparing acid-sensitive drugs for oral administration and the product soproduced
US2955982A (en) * 1951-01-22 1960-10-11 Parmelee Pharmaceutical Compan Continuous process for internally reinforcing salt tablets
US2707201A (en) * 1951-05-05 1955-04-26 Richardson Co Porous storage battery separator and method of making
US2719093A (en) * 1952-06-03 1955-09-27 William H Voris Methods of applying plastic coatings
BE538663A (fr) * 1954-06-25
US2894289A (en) * 1956-03-01 1959-07-14 Dow Chemical Co Method of making permeselective membranes
BE559907A (fr) * 1956-08-07
US2877159A (en) * 1957-04-26 1959-03-10 Ciba Pharm Prod Inc Method for preparing tablet granulations
US2928769A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of controlled release medicaments
US2928771A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of orally administrable controlled release medicaments

Also Published As

Publication number Publication date
BE585579A (fr) 1960-04-01
US3087860A (en) 1963-04-30
GB908016A (en) 1962-10-10

Similar Documents

Publication Publication Date Title
GB908016A (en) Prolonged release medicament and a method of producing the same
KR840005016A (ko) 서방출성 정제의 제조방법
US4931519A (en) Copolymers from n-alkyl-3-alkenylene-2-pyrrolidone
ES8604020A1 (es) Un procedimiento para la obtencion de polimeros porosos reticulados para liberacion controlada de farmacos
CA2041774A1 (fr) Utilisation d'amylose reticulee en tant que matrice pour la liberation lente de composes biologiquement actifs
DE19975055I1 (de) Propenylamine Verfahren zu ihrer Herstellung sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwending als Arzneimittel
KR930701983A (ko) 방출억제성 베라파밀 정제
KR970702028A (ko) 서방성 매트릭스 펠릿제 및 이들의 제조 방법 (Sustained-Release Matrix Pellets and Method for Preparing Them)
PT87285A (pt) Ibuprofen sustained release matrix and process
CA2016039A1 (fr) Formules pharmaceutiques a delitement progressif
MY109496A (en) Novel formulations of crop protection agents
NO870558L (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
YU46569B (sh) Postupak za porevlačenje tableta ili bolusa za kontrolisano oslobadjanje jedne ili više aktivnih supstanci
EP0088964A3 (en) Process for preparing insoluble, only slightly expandable polymers of basic vinyl-heterocyclic compounds, and their use
UA35569C2 (uk) Композиція для пролонгованого і контрольованого вивільнення пептидної лікарської речовини і спосіб її одержання, спосіб приготування суспензії, що призначена для парентерального введення
EP0868912A3 (fr) Utilisation de poudres polymères ou de granulés polymères pour enrober des formes d'administration pharmaceutiques ou agrochimiques
ATE81450T1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
ATE94410T1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
KR0177493B1 (ko) 단사정계 결정구조를 갖고 감열, 감광 및 감습성이 있는 활성성분을 함유하는 정제의 제조방법
ES2174930T3 (es) Composiciones de metronidazol de liberacion modificada y metodos para preparar y utilizar las mismas.
IT1250654B (it) Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
GB1218978A (en) Pharmaceutical compositions
GB1182124A (en) Process for the production of Pharmaceutical and like Beadlets
GB1108299A (en) Sustained release dosage forms and their preparation
ES380114A1 (es) Un procedimiento para la preparacion de una composicion pesticida solida.